Search
Medical Inquiry
MSL Visit
Company Information
Requests
Grants & Sponsorships
Investigator Sponsored Studies
Report an Adverse Event
Report an Product Quality Complaint
Resources
Congresses
Daridorexant
Insomnia Disease State
Other Target Therapy Areas
Contact Us
Menu
Search
Medical Inquiry
MSL Visit
Company Information
Requests
Grants & Sponsorships
Investigator Sponsored Studies
Report an Adverse Event
Report an Product Quality Complaint
Resources
Congresses
Daridorexant
Insomnia Disease State
Other Target Therapy Areas
Contact Us
A benefit-risk assessment of daridorexant for the treatments of insomnia using patient preference data from 2 phase 3 trials
This website is subject to the terms and conditions outlined in the legal and privacy statement.
Terms and Conditions
|
Privacy Policy
|
Feedback Survey
Copyright © 2024 Idorsia Pharmaceuticals Ltd
US Consumer (e.g., patient)
US Healthcare Professional